Abstract

Understanding the molecular mechanisms underlying frontotemporal dementia (FTD) is essential for the development of successful therapies. Systematic studies on human post-mortem brain tissue of patients with genetic subtypes of FTD are currently lacking. The Risk and Modyfing Factors of Frontotemporal Dementia (RiMod-FTD) consortium therefore has generated a multi-omics dataset for genetic subtypes of FTD to identify common and distinct molecular mechanisms disturbed in disease. Here, we present multi-omics datasets generated from the frontal lobe of post-mortem human brain tissue from patients with mutations in MAPT, GRN and C9orf72 and healthy controls. This data resource consists of four datasets generated with different technologies to capture the transcriptome by RNA-seq, small RNA-seq, CAGE-seq, and methylation profiling. We show concrete examples on how to use the resulting data and confirm current knowledge about FTD and identify new processes for further investigation. This extensive multi-omics dataset holds great value to reveal new research avenues for this devastating disease.

Details

Title
A multi-omics dataset for the analysis of frontotemporal dementia genetic subtypes
Author
Menden, Kevin 1   VIAFID ORCID Logo  ; Francescatto, Margherita 1 ; Nyima, Tenzin 1 ; Blauwendraat, Cornelis 2   VIAFID ORCID Logo  ; Dhingra, Ashutosh 1 ; Castillo-Lizardo, Melissa 1 ; Fernandes, Noémia 1 ; Kaurani, Lalit 3 ; Kronenberg-Versteeg, Deborah 4 ; Atasu, Burcu 4 ; Sadikoglou, Eldem 1 ; Borroni, Barbara 5 ; Rodriguez-Nieto, Salvador 1 ; Simon-Sanchez, Javier 4 ; Fischer, Andre 3 ; Craig, David Wesley 6 ; Neumann, Manuela 1 ; Bonn, Stefan 7   VIAFID ORCID Logo  ; Rizzu, Patrizia 1   VIAFID ORCID Logo  ; Heutink, Peter 1   VIAFID ORCID Logo 

 German Center for Neurodegenerative Diseases, Tübingen, Germany (GRID:grid.424247.3) (ISNI:0000 0004 0438 0426) 
 German Center for Neurodegenerative Diseases, Tübingen, Germany (GRID:grid.424247.3) (ISNI:0000 0004 0438 0426); National Institutes of Health, National Institute on Aging, Bethesda, USA (GRID:grid.94365.3d) (ISNI:0000 0001 2297 5165) 
 German Center for Neurodegenerative Diseases, Göttingen, Germany (GRID:grid.424247.3) (ISNI:0000 0004 0438 0426) 
 German Center for Neurodegenerative Diseases, Tübingen, Germany (GRID:grid.424247.3) (ISNI:0000 0004 0438 0426); Hertie Institute for Clinical Brain Research, Tübingen, Germany (GRID:grid.428620.a) 
 University of Brescia, Neurology Unit, Department of Clinical and Experimental Sciences, Brescia, Italy (GRID:grid.7637.5) (ISNI:0000 0004 1757 1846) 
 University of Southern California, California, USA (GRID:grid.42505.36) (ISNI:0000 0001 2156 6853) 
 German Center for Neurodegenerative Diseases, Tübingen, Germany (GRID:grid.424247.3) (ISNI:0000 0004 0438 0426); University Medical Center Hamburg-Eppendorf, Institute of Medical Systems Biology, Hamburg, Germany (GRID:grid.13648.38) (ISNI:0000 0001 2180 3484) 
Pages
849
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20524463
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2896064381
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.